You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Litigation Details for DISH Technologies L.L.C. v. lululemon athletica inc. (D. Del. 2021)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in DISH Technologies L.L.C. v. lululemon athletica inc.
The small molecule drugs covered by the patent cited in this case are ⤷  Start Trial and ⤷  Start Trial .

Litigation Summary and Analysis for DISH Technologies L.L.C. v. lululemon athletica inc. | 1:21-cv-00532

Last updated: March 3, 2026

Case Overview

DISH Technologies L.L.C. filed patent infringement litigation against lululemon athletica inc. in the U.S. District Court for the District of Colorado. The case, numbered 1:21-cv-00532, began in 2021 and concerns alleged infringement of patents related to wireless communication devices used in athletic and apparel products.

Patent Rights and Alleged Infringement

Patents Asserted

DISH asserts infringement of multiple patents related to wireless communication systems, specifically targeting:

  • U.S. Patent No. 10,631,895 (filed in March 2018, granted in April 2020)
  • U.S. Patent No. 10,787,474 (filed in September 2018, granted in September 2020)

The patents generally cover methods for wireless data transmission and device connectivity in wearable technology.

Products Accused

DISH claims that lululemon’s connected apparel, specifically the "Like New" series integrated with wireless sensors and communication modules, infringes patents. The products incorporate wireless communication features that DISH asserts fall within the scope of the patents.

Legal Claims

  • Patent infringement under 35 U.S.C. §§ 271(a), (b), and (c).
  • Anticipation and obviousness defenses implied but not explicitly detailed in initial filings.

Defense and Counterclaims

Lululemon has yet to file formal filings in this case. Historically, lululemon has contested patent claims on grounds such as non-infringement and invalidity, but no formal response has been publicly documented as of yet.

Procedural Status

  • Filed: April 8, 2021
  • Court: District of Colorado
  • Docket activity indicates discovery is ongoing.
  • Summary judgment motions are anticipated; no trial date set.

Strategic Significance

This case reflects increasing patent assertions in wearables and athletic apparel markets. DISH’s claims focus on core wireless communication technology embedded in wearable products, marking an aggressive approach to protecting innovations related to connectivity in sportswear.

Comparable Cases and Industry Context

Case Court Technology Focus Outcome Relevance
Apple Inc. v. Qualcomm N.D. California Wireless communication patents Settled in 2019 Demonstrates high stakes around wireless patents
Fitbit Inc. v. Garmin Ltd. N.D. California Wearable device patents Settled in 2019 Highlights patent disputes in wearables

Patent litigation in this sector often involves lengthy proceedings, with invalidity defenses and licensing negotiations common.

Potential Impacts

  • If DISH succeeds, lululemon could face significant licensing fees.
  • Lululemon may attempt to invalidate patents via inter partes review.
  • Broader industry trend of patent enforcement in connected apparel.

Key Legal Considerations

  • Patent scope. The claims cover wireless communication in wearable apparel.
  • Potential invalidity. Validity challenges could reshape the case.
  • Injunction risks. Court may grant an injunction against infringing products if infringement is found.

Key Takeaways

DISH Technologies L.L.C. has initiated patent infringement litigation against lululemon amid a surge in patent assertions over wearable connectivity technology. The case hinges on the interpretation of wireless communication patent claims and their application to connected athletic apparel. The outcome could influence licensing practices and patent enforcement strategies within the wearable and sportswear industries.

FAQs

Q1: What patents are involved in the DISH vs. lululemon case?
DISH asserts U.S. Patent Nos. 10,631,895 and 10,787,474, covering wireless communication methods in wearable technology.

Q2: What products does DISH claim infringe its patents?
DISH claims lululemon’s "Like New" connected apparel, which incorporates wireless sensors and modules.

Q3: What defenses might lululemon raise?
Lululemon could argue non-infringement or patent invalidity, including prior art references challenging validity.

Q4: How does this case compare to previous patent disputes in wearable tech?
It reflects a broader trend where technology companies and apparel brands contest patent rights over wireless features in sportswear.

Q5: What are the potential consequences for lululemon?
If found liable, lululemon could face licensing fees, injunctions, or product modifications to avoid infringement.


References

[1] U.S. Patent and Trademark Office. (2023). Patent database.
[2] District of Colorado Court Docket. (2023). Case 1:21-cv-00532.
[3] Industry reports and patent filings related to wearable wireless technology.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.